Paper Details

  1. Home
  2. Paper Details

Risedronate, a novel pyridinyl bisphosphonate for the treatment of osteoporosis and Paget's disease of bone.

Author: LicataA A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Risedronate, a novel pyridinyl bisphosphonate, is effective and well-tolerated in the treatment of Paget's disease of bone. It has a shorter treatment regimen compared to other oral bisphosphonates. Risedronate is also being investigated for the treatment of postmenopausal and corticosteroid-induced osteoporosis.
Paper Details　
Original Abstract of the Article :
Osteoporosis and Paget's disease of bone are the most common metabolic bone diseases. They cause considerable disability and pain, and reduce quality of life. The elderly are at greatest risk of osteoporotic fractures, and in an ageing world population, the burden of the disease is likely to increas...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/13543784.8.7.1093

データ提供：米国国立医学図書館（NLM）

Risedronate: A New Hope in the Treatment of Osteoporosis and Paget's Disease of Bone

Osteoporosis and Paget's disease of bone are chronic bone diseases that can be debilitating, like a relentless sandstorm eroding away bone density. This study explores the potential of risedronate, a novel pyridinyl bisphosphonate, as a treatment for these conditions.

Risedronate: A Promising Treatment for Bone Diseases

Risedronate has demonstrated efficacy and tolerability in treating Paget's disease. Notably, it boasts the shortest treatment regimen among oral bisphosphonates, offering a two-month course of therapy for sustained remission.

Strengthening Bones: A Journey Through the Desert of Bone Disease

This study suggests that risedronate may offer a valuable therapeutic option for treating osteoporosis and Paget's disease, paving the way for healthier bones and a more robust skeletal system.

Dr.Camel's Conclusion

Just as the desert holds hidden oases, research continues to uncover promising solutions for treating debilitating bone diseases. This study underscores the potential of risedronate as a powerful tool in the fight against osteoporosis and Paget's disease.

Date :
  1. Date Completed 2005-07-19
  2. Date Revised 2019-09-17
Further Info :

Pubmed ID

15992109

DOI: Digital Object Identifier

10.1517/13543784.8.7.1093

Related Literature

Article Analysis
・Side Effects of risedronate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.